Journal profile · Gastroenterology & Hepatology
Digestive and Liver Disease
ISSN 1590-8658 · eISSN 1878-3562 · Elsevier · ITALY · Monthly · Founded 2000
Digestive and Liver Disease: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.87; fully open access; APC about USD 3,300; median 74 days to acceptance (100 articles, last 24 months); community-reported acceptance: fairly easy; 1,027 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Digestive and Liver Disease is published by Elsevier and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Liver Disease Diagnosis and Treatment, Inflammatory Bowel Disease and Liver Disease and Transplantation, together about 25.4% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of: AISF, AISP, AIGO, SIGE, SIGENP, IG-IBD, HelSPGHANDigestive and Liver Disease is an international journal of Gastroenterology and Hepatology. It is the official journal of Italian Association for the Study of the Liver (AISF); Italian Association for the Study of the Pancreas (AISP); Italian Association for Hospital Gastroenterologists and Digestive Endoscopists (AIGO); Italian Society of Gastroenterology (SIGE); Italian Society of Pediatric Gastroenterology and Hepatology (SIGENP), Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Hellenic Society of Pediatric Gastroenterology, Hepatology and Nutrition (HelSPGHAN).Digestive and Liver Disease publishes papers on basic and clinical research in the field of gastroenterology and hepatology.Contributions consist of:Original PapersCorrespondence to the EditorEditorials, Reviews and Special ArticlesPosition Papers, GuidelinesProgress ReportsImage of the MonthCongress ProceedingsSymposia and Mini-symposia
From the journal's Aims & Scope
Research area (LetPub): Gastroenterology & Hepatology
Editor-in-chief Roberto de Franchis MilanPublisher website
Editorial board by country: 2 in mainland China (about 1%); most named Italy 109, United States 19, France 15, United Kingdom 4, Canada 3 (167 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Liver Disease Diagnosis and TreatmentMedicine12.2%
- Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology6.8%
- Liver Disease and TransplantationMedicine6.4%
- Microscopic ColitisMedicine5.9%
- Hepatitis C virus researchMedicine5.3%
- Helicobacter pylori-related gastroenterology studiesMedicine4.5%
- Esophageal and GI PathologyMedicine4.4%
- Gastric Cancer Management and OutcomesMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.87LetPub ·
- Impact factor (publisher)
- 4.9Publisher website ·
- CiteScore 2026-06
- 6.4LetPub ·
- CiteScore (publisher)
- 6.4Publisher website ·
- SJR 2026-06
- 1.22LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 84LetPub ·
- h-index
- 131OpenAlex ·
- i10-index
- 3,564OpenAlex ·
- 2-year mean citedness
- 1.17OpenAlex ·
- Self-citation rate
- 6.1%LetPub ·
- Share of gold OA articles
- 23.22%LetPub ·
Volume
- Articles per year
- 260LetPub ·
Articles by year OpenAlex count · 21,385 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 656 | 655 | 81 |
| 2025 | 1,027 | 143 | 891 |
| 2024 | 913 | 164 | 2,055 |
| 2023 | 778 | 182 | 3,026 |
| 2022 | 604 | 123 | 3,254 |
| 2021 | 726 | 137 | 4,310 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
74 daysMedian, submission to acceptance · P25–P75 19 days – 121 days
- Acceptance to online
- median 22 days (100 articles)
- Submission to online
- median 96 days
- Sample
- 100 articles with submission and acceptance dates (832 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 40 daysPublisher website ·
- Submission to acceptance
- 33 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,300 / EUR 3,090 / GBP 2,640 / JPY 409,300 | — | — | |
| Publisher website | USD 2,960 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 200 words
- Keywords
- ≥ 2
- Manuscript length
- ≤ 3,500 words
- Reference style
- Numbered, in order of citation
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted13, with length limits
- congress proceedingsOther Publications Congress proceedings, generally in the form of selected abstracts, may be considered for publication.Length not stated
- editorialOriginal PapersThe maximum length is 3,500 words, excluding the abstract, references, tables and figures. The abstract should be structured and not exceed 200 w…main text ≤ 700 words · references ≤ 15
- editorials and commentariesEditorials and Commentaries These manuscripts are accepted only upon invitation from the Editorial Board. The maximum length is 700-1000 words. No more than 15 …Length not stated
- image of the monthImage of the Month Only exceptional or particularly captivating images will be accepted for publication. Submissions should include no more than 2 Figures. The …Length not stated
- letterOriginal PapersThe maximum length is 3,500 words, excluding the abstract, references, tables and figures. The abstract should be structured and not exceed 200 w…Length not stated
- letters to the editorchecklist included with the submission. Letters to the Editor Letters to the Editors should be up to 1500 words long, with no more than 6 authors, 1 or 2 images…main text ≤ 1,500 words · references ≤ 10
- newsNews regarding recent books, forthcoming congresses and symposia, as well as scientific societies involved in the area of gastroenterology and/or hepatology, ma…Length not stated
- original paperymposia and Mini-symposia Article types Original Papers The maximum length is 3,500 words, excluding the abstract, references, tables and figures. Thmain text ≤ 3,500 words · abstract ≤ 200 words
- original papersOriginal Papers The maximum length is 3,500 words, excluding the abstract, references, tables and figures. The abstract should be structured and not exceed 200 …Length not stated
- reviewOriginal PapersThe maximum length is 3,500 words, excluding the abstract, references, tables and figures. The abstract should be structured and not exceed 200 w…Length not stated
- review articleReview articles are usually considered only upon invitation from the Editorial Board. No more than 6 authors may be listed as contributors. Manuscript should co…main text ≤ 200 words · abstract ≤ 200 words
- review articlesReview Articles Review articles are usually considered only upon invitation from the Editorial Board. No more than 6 authors may be listed as contributors. Manu…Length not stated
- supplementsSupplements to the journal containing extended abstracts, or full papers may also be taken into consideration.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Peer review type: single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- ITALY
- Language
- English
- Frequency
- Monthly
- Founded
- 2000
- ISSN
- 1590-8658
- Electronic ISSN
- 1878-3562
- Society / sponsor
- Italian Association for the Study of the Liver
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Digestive and Liver Disease
What CAS zone is Digestive and Liver Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Digestive and Liver Disease is in Zone 2 of Medicine, and in Zone 3 of the minor category Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Digestive and Liver Disease?
The latest impact factor listed by LetPub is 4.87; CiteScore 6.4, h-index 131.
How long does peer review take at Digestive and Liver Disease?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 74 days (interquartile range 19–121 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Digestive and Liver Disease?
According to the journal's author guidelines: Abstract: ≤ 200 words; Keywords: ≥ 2; Manuscript length: ≤ 3,500 words; Reference style: Numbered, in order of citation; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Digestive and Liver Disease based?
Of the 167 board members whose country the journal's board page names, 2 (about 1%) are in mainland China; the countries named most often are Italy (109), United States (19) and France (15). Counted from the institutions listed on the board page; for reference only.
Which databases index Digestive and Liver Disease?
According to LetPub and DOAJ records, Digestive and Liver Disease is indexed in SCIE and Scopus.
Is Digestive and Liver Disease open access, and what is the APC?
Digestive and Liver Disease is a fully open-access journal. APC about USD 3,300.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .